Glenmede Trust’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Glenmede Trust's ACLS Position: Q1 2026 in Review
Glenmede Trust increased its Axcelis (ACLS) stake by 1.1% in Q1 2026, buying an estimated $2.66K and bringing the position to 2,640 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1229.
Glenmede Trust first reported a position in ACLS in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.31M in Q3 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Glenmede Trust held 2,640 shares of Axcelis worth $246K as of Q1 2026.
- Glenmede Trust bought 30 Axcelis shares in Q1 2026, an estimated $2.66K.
- Axcelis made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1229 holding.
- Glenmede Trust first reported a position in Axcelis in Q2 2013 and has held it in 21 quarters since.
- Glenmede Trust's Axcelis position peaked at $1.31M in Q3 2023.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.